307 related articles for article (PubMed ID: 17326765)
1. Defective peripheral nerve myelination and neuromuscular junction formation in fukutin-deficient chimeric mice.
Saito F; Masaki T; Saito Y; Nakamura A; Takeda S; Shimizu T; Toda T; Matsumura K
J Neurochem; 2007 Jun; 101(6):1712-22. PubMed ID: 17326765
[TBL] [Abstract][Full Text] [Related]
2. Aberrant neuromuscular junctions and delayed terminal muscle fiber maturation in alpha-dystroglycanopathies.
Taniguchi M; Kurahashi H; Noguchi S; Fukudome T; Okinaga T; Tsukahara T; Tajima Y; Ozono K; Nishino I; Nonaka I; Toda T
Hum Mol Genet; 2006 Apr; 15(8):1279-89. PubMed ID: 16531417
[TBL] [Abstract][Full Text] [Related]
3. The role of dystroglycan, a novel receptor of laminin and agrin, in cell differentiation.
Matsumura K; Yamada H; Saito F; Sunada Y; Shimizu T
Histol Histopathol; 1997 Jan; 12(1):195-203. PubMed ID: 9046055
[TBL] [Abstract][Full Text] [Related]
4. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses.
Côté PD; Moukhles H; Lindenbaum M; Carbonetto S
Nat Genet; 1999 Nov; 23(3):338-42. PubMed ID: 10610181
[TBL] [Abstract][Full Text] [Related]
5. [Alpha-dystroglycanopathy (FCMD, MEB, etc): abnormal glycosylation and muscular dystrophy].
Toda T
Rinsho Shinkeigaku; 2005 Nov; 45(11):932-4. PubMed ID: 16447766
[TBL] [Abstract][Full Text] [Related]
6. [Dystroglycan linkage and muscular dystrophy].
Shimizu T
Rinsho Shinkeigaku; 2002 Nov; 42(11):1091-4. PubMed ID: 12784674
[TBL] [Abstract][Full Text] [Related]
7. Aberrant glycosylation of alpha-dystroglycan causes defective binding of laminin in the muscle of chicken muscular dystrophy.
Saito F; Blank M; Schröder J; Manya H; Shimizu T; Campbell KP; Endo T; Mizutani M; Kröger S; Matsumura K
FEBS Lett; 2005 Apr; 579(11):2359-63. PubMed ID: 15848172
[TBL] [Abstract][Full Text] [Related]
8. Glycosylation defects: a new mechanism for muscular dystrophy?
Grewal PK; Hewitt JE
Hum Mol Genet; 2003 Oct; 12 Spec No 2():R259-64. PubMed ID: 12925572
[TBL] [Abstract][Full Text] [Related]
9. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.
Michele DE; Barresi R; Kanagawa M; Saito F; Cohn RD; Satz JS; Dollar J; Nishino I; Kelley RI; Somer H; Straub V; Mathews KD; Moore SA; Campbell KP
Nature; 2002 Jul; 418(6896):417-22. PubMed ID: 12140558
[TBL] [Abstract][Full Text] [Related]
10. Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages.
Meinen S; Barzaghi P; Lin S; Lochmüller H; Ruegg MA
J Cell Biol; 2007 Mar; 176(7):979-93. PubMed ID: 17389231
[TBL] [Abstract][Full Text] [Related]
11. Co-localization of fukutin and alpha-dystroglycan in the mouse central nervous system.
Ohtsuka-Tsurumi E; Saito Y; Yamamoto T; Voit T; Kobayashi M; Osawa M
Brain Res Dev Brain Res; 2004 Sep; 152(2):121-7. PubMed ID: 15351499
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
[TBL] [Abstract][Full Text] [Related]
13. An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.
Moll J; Barzaghi P; Lin S; Bezakova G; Lochmüller H; Engvall E; Müller U; Ruegg MA
Nature; 2001 Sep; 413(6853):302-7. PubMed ID: 11565031
[TBL] [Abstract][Full Text] [Related]
14. Fukutin expression in mouse non-muscle somatic organs: its relationship to the hypoglycosylation of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy.
Saito Y; Yamamoto T; Ohtsuka-Tsurumi E; Oka A; Mizuguchi M; Itoh M; Voit T; Kato Y; Kobayashi M; Saito K; Osawa M
Brain Dev; 2004 Oct; 26(7):469-79. PubMed ID: 15351084
[TBL] [Abstract][Full Text] [Related]
15. Molecular interaction between fukutin and POMGnT1 in the glycosylation pathway of alpha-dystroglycan.
Xiong H; Kobayashi K; Tachikawa M; Manya H; Takeda S; Chiyonobu T; Fujikake N; Wang F; Nishimoto A; Morris GE; Nagai Y; Kanagawa M; Endo T; Toda T
Biochem Biophys Res Commun; 2006 Dec; 350(4):935-41. PubMed ID: 17034757
[TBL] [Abstract][Full Text] [Related]
16. Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking alpha- and beta1-syntrophins.
Shiao T; Fond A; Deng B; Wehling-Henricks M; Adams ME; Froehner SC; Tidball JG
Hum Mol Genet; 2004 Sep; 13(17):1873-84. PubMed ID: 15238508
[TBL] [Abstract][Full Text] [Related]
17. The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane.
Jacobson C; Côté PD; Rossi SG; Rotundo RL; Carbonetto S
J Cell Biol; 2001 Feb; 152(3):435-50. PubMed ID: 11157973
[TBL] [Abstract][Full Text] [Related]
18. Intracellular binding of fukutin and alpha-dystroglycan: relation to glycosylation of alpha-dystroglycan.
Yamamoto T; Kawaguchi M; Sakayori N; Muramatsu F; Morikawa S; Kato Y; Shibata N; Kobayashi M
Neurosci Res; 2006 Dec; 56(4):391-9. PubMed ID: 17005282
[TBL] [Abstract][Full Text] [Related]
19. Basement membrane fragility underlies embryonic lethality in fukutin-null mice.
Kurahashi H; Taniguchi M; Meno C; Taniguchi Y; Takeda S; Horie M; Otani H; Toda T
Neurobiol Dis; 2005; 19(1-2):208-17. PubMed ID: 15837576
[TBL] [Abstract][Full Text] [Related]
20. Effects of fukutin deficiency in the developing mouse brain.
Chiyonobu T; Sasaki J; Nagai Y; Takeda S; Funakoshi H; Nakamura T; Sugimoto T; Toda T
Neuromuscul Disord; 2005 Jun; 15(6):416-26. PubMed ID: 15907289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
